Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Office
417 N. 8th Street
Suite 201
Philadelphia, PA, 19123
USA

People

Co-Founder
Co-Founder
Co-Founder
Software Engineer

Funding

TOTAL $300k
FUNDING TOTAL $300k
Seed, 7/2013
DreamIt Ventures
Equity Crowdfunding, 12/2013
$300k
DEBT TOTAL $993k
Debt, 1/2014
$993k

Tags

Biomeme

Biomeme’s platform transforms your smartphone into a mobile lab for advanced DNA diagnostics and real-time disease surveillance. The system includes a docking station for real-time qPCR, a mobile app to control the system and analyze results, and targeted test kits for preparing samples and identifying pathogens or diseases by their specific DNA or RNA signatures. The cutting edge platform performs to the gold standard used by the world’s most advanced central labs but requires no lab equipment or special experience to use.

The low-cost, user-friendly system enables mobile testing at the point-of-need for health care (mobile clinics, disease tracking, home use), agriculture (plant disease tracking, food safety), vector surveillance (Malaria, West Nile mosquitos), veterinary medicine, environmental monitoring (soil and water safety), and even education and citizen science.

Recent Milestones

Videos

Screenshots

Biomeme screenshot
Above: Biomeme Mobile Docking Station
Uploaded: 7/22/13
Biomeme screenshot
Above: Biomeme Test Kits
Uploaded: 7/22/13
Biomeme screenshot
Above: Biomeme Logo
Uploaded: 7/23/13

Sources

  1. New incubator DreamIt Health launches first class (mobihealthnews.com) [edit]
  2. Biomeme raises $300k on equity crowdfunding platform Microventures (technical.ly) [edit]
  3. SEC (sec.gov) [edit]
Edit This Page
Last Edited 3/4/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

TechCrunch Posts TechCrunch Logo Small Picture

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy